Weikang Tao, CEO of Shanghai Hengrui Pharmaceutical Co.,TLD., R&D center and VP of Hengrui Medicine, China
Chang Bai, VP of Shanghai Hengrui Pharmaceutical Co.,TLD., R&D center, China
Feng He, VP of Shanghai Hengrui Pharmaceutical Co.,TLD., R&D center, China
Dafang Zhong, Director of Drug metabolism, Shanghai Institute of Pharmaceuticals, Chinese Academy of Sciences, China
Johan Gabrielsson, Professor of integrative pharmacology, Uppsala, Sweden
Emre Isin, Director, Head of Biotransformation and Enzymology, UCB Biopharma, Belgium
Zeping Hu, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China
Jiuming He, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Xuanjia Peng, Head of DEL (DNA-Encoded Library), WuXi AppTec, China
Jie Wang, Site Director of Hengrui Nanjing Research Institute, China
Jingwu Kang, The state key laboratory for bioorganic chemistry, Shanghai institute of organic chemistry, Chinese academy of sciences, China
Hongming Chen, Principal Investigator of Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), China
Hui Ye, Associate Professor, State Key Laboratory of Natural Medicines, China Pharmaceutical University, China
Godefridus J. Peters, VU University Medical Center Amsterdam, The Netherlands
Alex Avdeef, CEO, In ADME Research, USA
Kiyohiko Sugano, Professor, Ritsumeikan University, Japan
Klara Valko, CEO, Biomimetic chromatography Ltd., UK
Rolf Hilfiker, Head of the Department Solid-State Development, Solvias AG, Switzerland
Hongcan Ren, Principal Scientist of Hutchison Medipharma Ltd., China
Xiaoqiang Xiang, Assoc. Prof , Acting director of Dept. of Clinical Pharmacy and Drug Administration, School of Pharmacy, Fudan University, China
Yang Lu, Assoc. Prof , Clinical Pharmacokinetics Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, China
Kin Tam, Assoc. Prof, Faculty of Health Sciences, University of Macau, Chief Editor of ADMET & DMPK, Macau
Yong-Moon Lee, Chungbuk National University, Republic of Korea
Hong Zhuang, Sr. Director of Turning Point Therapeutics, USA
Hua Lv, Clinical Pharmacology Director, Jiangsu Hengri Medicine CO., TLD., China
Jiaan Yang, CEO, Shanghai Micro Pharmatech, China
Xi Zhu, Director of Shanghai INNOSTAR Co., Ltd, China
Guocai Lu, CEO of CTI Biotechnology (Suzhou) Co., Ltd, China
Xiaobo Cen, CEO of West China-Frontier PharmaTech Co., Ltd, China
Xing Sun, Director of Shanghai Shengdi, China
Henry Li, CSO of Crown Bioscience (Taicang) Inc., China
Henry Kwok, Assoc. Prof, Faculty of Health Sciences, University of Macau, Macau
Ying Fu, Professor, Applied electromagnetics, School of Information Technology, Halmstad University, Sweden Molecular Bioimaging
Zheming Gu, Gennral Manager of Value Pharmaceutical Services, China Metabolite profiling and mass balance
Jing Li, CSO of Eternity Bioscience Inc, affiliated with Jangsu Hengrui Medicine, USA Hit finding and Lead screening
Mingyue Zheng, Professor, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China Drug design and AI
Pingyan Bie, Senior Director of Medicinal Chemistry, Zhejiang Hisun Pharmaceutical Co. Ltd., China Drug discovery
Bob Zhang, CEO, Kunming Biomed International (KBI), China Translational animal model
Ismael Zamora, CEO, Lead Molecular Design, S.L., and Associate Professor, Universitat Pompeu Fabra, Spain
Wouter Driessen, Principal scientist and DMPK/PD project leader, Roche Basel, Switzerland
Duanyun Si, Excutive Director of State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, China
Christel Bergström, Professor, Uppsala University, Sweden
Kimiyoshi Ichida, Professor at the Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Japan
Fan Wu, Senior Principal Scientist at Bristol-Myers Squibb, USA
Sylvia Zhao, Executive Director, PK Sciences China/Japan Site Head, Novartis Institute of BioMedical Research (NIBR)
Sami Svanbäck, CEO, The Solubility Company, Finland
Yutai Li, Principal Scientist, Merck & Co., Safety assessment and laboratory animal resources, USA